Skip to main content

News and blog posts

23
Jun 2022

National care program for breast cancer updated in Sweden

On May 31, 2022, Regional Cancer Centers collaboration (RCC) updated the national care program for breast cancer. New and updated recommendations concerned genetic testing, molecular diagnostic, de-escalation of surgical treatment for certain patient groups, radiotherapy regimens, and pharmacotherapy. A new chapter was added on breast cancer in men.
21
Jun 2022

Regular update of the Norwegian Laboratory Code System released

In late May 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system to be implemented no later than July 01, 2022, and associated tariffs for state and private laboratories to be implemented no later than June 01, 2022. NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings.
14
Jun 2022

CCAM and NGAP Nomenclatures updated in France

On May 31, 2022, a decision of the National Union of Health Insurance Funds relating to the update of the Nomenclatures of procedures - Common classification of medical procedures (CCAM) and General nomenclature of professional acts (NGAP) - was published in the Official Journal of the French Republic. Various changes were introduced in the CCAM, such as the inclusion of new procedure codes, provisionally registered codes, and modification of the billing conditions. New CCAM codes were introduced in the field of ophthalmology, men’s health, and diagnostic imaging. These changes will be reflected in version 70 of the CCAM nomenclature, which will enter into force on June 30, 2022.
08
Jun 2022

Belgian INAMI-RIZIV updated the List of reimbursable devices

On May 25, 2022, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published an updated List of reimbursable devices that came into force on June 01, 2022. A total of 12 new codes with the corresponding conditions of reimbursement were added to the List, which concerned sacral neurostimulation in fecal incontinence treatment, soft tissue markers, and osteosynthesis devices.